Characteristics | Cases | NSBP1 immunoreactivity | P | |||||
---|---|---|---|---|---|---|---|---|
 |  | - | + | ++ |  | |||
 |  | Cases (%) | Cases (%) | Cases (%) |  | |||
Gender | Â | Â | Â | Â | Â | Â | Â | 0.653 |
Male | 129 | 18 | 11.8 | 33 | 21.7 | 78 | 51.3 | Â |
Female | 23 | 3 | 2.0 | 8 | 5.3 | 12 | 7.9 | Â |
Age (years) | 60.4 ± 8.9 | 59.8 ± 9.7 | 60.2 ± 9.8 | 61.3 ± 11 |  | |||
Grade | Â | Â | Â | Â | Â | Â | Â | 0.040* |
1 | 0 | 0 | Â | 0 | Â | 0 | Â | Â |
2 | 63 | 14 | 9.2 | 16 | 10.5 | 33 | 21.7 | Â |
3 | 89 | 7 | 4.6 | 25 | 16.5 | 57 | 37.5 | Â |
Pathologic stage | Â | Â | Â | Â | Â | Â | Â | 0.002** |
T1 | 18 | 10 | 6.6 | 5 | 3.3 | 3 | 2.0 | Â |
T2 | 35 | 6 | 3.9 | 12 | 7.9 | 17 | 11.1 | Â |
T3 | 47 | 3 | 2.0 | 15 | 9.9 | 29 | 19.1 | Â |
T4 | 52 | 2 | 1.3 | 9 | 5.9 | 41 | 27.0 | Â |